Article Details

Madrigal Pharmaceuticals (NASDAQ:MDGL) Given Buy Rating at Goldman Sachs Group

Retrieved on: 2018-06-07 04:15:00

Tags for this article:

Click the tags to see associated articles and topics

Madrigal Pharmaceuticals (NASDAQ:MDGL) Given Buy Rating at Goldman Sachs Group. View article details on hiswai:

Excerpt

<div>EAM Global Investors LLC purchased a new stake in shares of Madrigal Pharmaceuticals in the first quarter worth about $946,000. <b>WINTON GROUP</b> ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up